Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Oxford Finance LLC

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 144
Average round size
The average size of a deal this fund participated in
Portfolio companies 131
Rounds per year 7.20
Lead investments 32
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 79
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical

In 2002 was created Oxford Finance LLC, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Alexandria.

Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Biopharma. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Avanir Pharmaceuticals, Auspex Pharmaceuticals, Ignyta.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Oxford Finance LLC, startups are often financed by Versant Ventures, Silicon Valley Bank, Venrock. The meaningful sponsors for the fund in investment in the same round are MidCap Financial, Silicon Valley Bank, Square 1 Bank. In the next rounds fund is usually obtained by Vivo Capital, Versant Ventures, Accuitive Medical Ventures.

The fund is constantly included in 7-12 deals per year. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. Considering the real fund results, this Corporate Investor is 6 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Oxford Finance LLC performs on 22 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Oxford Finance LLC:
Typical Co-investors
Oxford Finance LLC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Oxford Finance LLC:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Chagral Invest -
DJR Advisors -
Emerging Longevity Ventures -
Fleet Development Ventures Boston, Massachusetts, United States
Kupanda Holdings -
Pinewood Studios Group Buckingham, Buckinghamshire, United Kingdom
Property Agent Japan, Tokyo
Siem Offshore Contractors Germany, Leer, North Rhine-Westphalia
Startup Autobahn Baden-Wurttemberg, Germany, Stuttgart
Tapit Partners California, Healdsburg, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pearl Street Dental Management

Human Resources
Management Consulting
$115M16 Nov 2022 Dallas, Texas, United States

Renibus Therapeutics

Health Care
$10M14 Nov 2022 -

ALX Oncology

Health Care
Life Science
$100M31 Oct 2022 San Francisco, California, United States

Verona Pharma

$150M17 Oct 2022 London, England, United Kingdom


Health Care
$40M22 Jun 2022 Menlo Park, California, United States

SeLux Diagnostics

Health Care
Health Diagnostics
$30M01 Jun 2022 Boston, Massachusetts, United States

Silk Road Medical

Health Care
Medical Device
$250M31 May 2022 Sunnyvale, California, United States

Verastem Oncology

$25M28 Mar 2022 Massachusetts, United States

Lexicon Pharmaceuticals

$150M17 Mar 2022 The Woodlands, Texas, United States
Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.
– Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the Kala’s marketing of its two approved ophthalmic products.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oxford Finance LLC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: